{"ticker": {"uuid": "0b49a43b-d959-4761-93b4-635544b6e4fe", "symbol": "MVP", "name": "Medical Developments International Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOVWJYTUVJSW9ybURTSzhiM0h2SjlkZkZ3NjNQajhRNGNVN3dXTDZCSVlycXlSM3ozQlhzOTJfcDB2cWk0YlJtaWZCUlhrNk9pak9uOFdwa3Z5ZjJVU0xLLTRHTVEzREtyaW1UQ3B3V09FVDV3U3htQ051eGdYdnN5eXVDNXZNNWNVcGZFamt2czVIWWtQNG1VTTl1aEFNR21XRlMzandjeTBYMmpxRG9sUmJleFdHaDQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International builds momentum as Penthrox growth offsets softer respiratory demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQeVBMRjZFcGRzbmx1TWd6ZHp3OWlDOVpHM19xSjdvdWVHV1BjWlZlWWI2RDh3UlNlQ0dFSVFNZldqUkFSa2VXTlltQmI1dWpzTWlvSEJ4RlVtdWp4TmV5Y2h3TDlpZnhNZzFBSGtlQlAxaU41XzJFYzdTSXV1VTR4NXpfM3RnWUlJUGx4N1J1RDFVNHVFajZyRWRYN080VzRZVTVlbVYtLXY0U0I1eS1hdU1DWmRGX29FZk8zOHduc3ZfbW8?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International signals a turn to growth as Penthrox momentum builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOMDJlWHJiRHNQSDJ5S1RJa1A0ZlAtZHMzWlhxNC1CbXNFTGpWWHFPV251WjMydWFCd0JSTFBjMkUwVG5uNFN3WE1Ta3hveU55Z0Fvczh3MmhabzFsWnFOamZ0MkRWdEtvN1FMSERVU1pzMk1PSGtYME43cHFrNFJCcVNETVo1S1NUYTFyUE5qcEhLZU0yZmI5TG5FZUhFNWg5RmZHdjN5MmtGeW5WTWYwb1R3TkJjOHVDb1h6ZGdCZXo?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-10-13T07:00:00+00:00", "published_display": "13 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-18T07:00:00+00:00", "published_display": "18 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders in Medical Developments International (ASX:MVP) have lost 90%, as stock drops 13% this past week", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNaF9HMHR2YlE1Vm5WbWRkTFBrSW15VS1LdkRvZUNHdUpvRFdPQnhyeEJsZ3lPSklIaDFuUWZyb19fVlN3Qllkc052alFWVm54SFh5MGZwVG5uVHBSZEx4S04wWjhnejRnVkNDanBieWdrcWlUSjF5QTRudUNKbC1rV3d1V3dsMzNoQjV1Smx4bmFUOW95Ry1vclRuc2ItQQ?oc=5", "source_name": "Market source", "published_at": "2025-02-21T08:00:00+00:00", "published_display": "21 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Getting high on Medical Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPMlVQWmI0cDEzQUVyUGdDbTVRdERDbFF2Vng3SENrQkNySl80TGpuTXdoTTVRcndIcFhZOVpHQ0ktR1p6RkNGX1RCWUNLZGxqTy1ScV9kYy0za1FTaVMxQ1NWUUhKZTRvQWtWZGFnYWNrVnhnZE1RcFNEbXVHeEVvclNYZ2lsUDZWYW53RUozMjNvWG1rVnF3Ynh0dXAwcXM?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2021-09-22T07:00:00+00:00", "published_display": "22 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX: MVP) - Dividends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQY3BYejFsS1V0ZFVWLS11T0poc1dfcFFqdFZhcGdZU1k1TzlmNkxodHl3bndfelFuQ0RxblJ3VGRhamZJSUpkUWFqUk1Yb0hKYzZrdzZxaDF6c3RuUjRBNHUzaUJJMW51RHRWc0dWRkY3QlI3dm1tS3FPTkVnbHlxblB0SjJMbGZ6cDFpclMzaVRGT0lzeFNWZU9waW5jN01CdWRudGJXb2tjQQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T04:06:02+00:00", "published_display": "27 Sep 2019 04:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX:MVP) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxORkxYNzZraG5YM2FEcVdWRWtia2FpNjl6OVZrdUJYZlZXeHRITmRPY2l6OC1xdkIzWXZwTGh4aU5ZcW5jZFFNb09wajkyV0JIcUktVXNkLTJJNUxlTUpoVEMxTzV5R0REVjNialU2QlgzTkNmWDFHbmFhUlRTZFp0WFBJaVgzZ3NIN0wtLTV4b1Zqb3BGSjBFbE1mTmc?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-23T12:16:11+00:00", "published_display": "23 Sep 2019 12:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOVWJYTUVJSW9ybURTSzhiM0h2SjlkZkZ3NjNQajhRNGNVN3dXTDZCSVlycXlSM3ozQlhzOTJfcDB2cWk0YlJtaWZCUlhrNk9pak9uOFdwa3Z5ZjJVU0xLLTRHTVEzREtyaW1UQ3B3V09FVDV3U3htQ051eGdYdnN5eXVDNXZNNWNVcGZFamt2czVIWWtQNG1VTTl1aEFNR21XRlMzandjeTBYMmpxRG9sUmJleFdHaDQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International builds momentum as Penthrox growth offsets softer respiratory demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQeVBMRjZFcGRzbmx1TWd6ZHp3OWlDOVpHM19xSjdvdWVHV1BjWlZlWWI2RDh3UlNlQ0dFSVFNZldqUkFSa2VXTlltQmI1dWpzTWlvSEJ4RlVtdWp4TmV5Y2h3TDlpZnhNZzFBSGtlQlAxaU41XzJFYzdTSXV1VTR4NXpfM3RnWUlJUGx4N1J1RDFVNHVFajZyRWRYN080VzRZVTVlbVYtLXY0U0I1eS1hdU1DWmRGX29FZk8zOHduc3ZfbW8?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International signals a turn to growth as Penthrox momentum builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOMDJlWHJiRHNQSDJ5S1RJa1A0ZlAtZHMzWlhxNC1CbXNFTGpWWHFPV251WjMydWFCd0JSTFBjMkUwVG5uNFN3WE1Ta3hveU55Z0Fvczh3MmhabzFsWnFOamZ0MkRWdEtvN1FMSERVU1pzMk1PSGtYME43cHFrNFJCcVNETVo1S1NUYTFyUE5qcEhLZU0yZmI5TG5FZUhFNWg5RmZHdjN5MmtGeW5WTWYwb1R3TkJjOHVDb1h6ZGdCZXo?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-10-13T07:00:00+00:00", "published_display": "13 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-18T07:00:00+00:00", "published_display": "18 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders in Medical Developments International (ASX:MVP) have lost 90%, as stock drops 13% this past week", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNaF9HMHR2YlE1Vm5WbWRkTFBrSW15VS1LdkRvZUNHdUpvRFdPQnhyeEJsZ3lPSklIaDFuUWZyb19fVlN3Qllkc052alFWVm54SFh5MGZwVG5uVHBSZEx4S04wWjhnejRnVkNDanBieWdrcWlUSjF5QTRudUNKbC1rV3d1V3dsMzNoQjV1Smx4bmFUOW95Ry1vclRuc2ItQQ?oc=5", "source_name": "Market source", "published_at": "2025-02-21T08:00:00+00:00", "published_display": "21 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Getting high on Medical Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPMlVQWmI0cDEzQUVyUGdDbTVRdERDbFF2Vng3SENrQkNySl80TGpuTXdoTTVRcndIcFhZOVpHQ0ktR1p6RkNGX1RCWUNLZGxqTy1ScV9kYy0za1FTaVMxQ1NWUUhKZTRvQWtWZGFnYWNrVnhnZE1RcFNEbXVHeEVvclNYZ2lsUDZWYW53RUozMjNvWG1rVnF3Ynh0dXAwcXM?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2021-09-22T07:00:00+00:00", "published_display": "22 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX: MVP) - Dividends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQY3BYejFsS1V0ZFVWLS11T0poc1dfcFFqdFZhcGdZU1k1TzlmNkxodHl3bndfelFuQ0RxblJ3VGRhamZJSUpkUWFqUk1Yb0hKYzZrdzZxaDF6c3RuUjRBNHUzaUJJMW51RHRWc0dWRkY3QlI3dm1tS3FPTkVnbHlxblB0SjJMbGZ6cDFpclMzaVRGT0lzeFNWZU9waW5jN01CdWRudGJXb2tjQQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T04:06:02+00:00", "published_display": "27 Sep 2019 04:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Developments International Limited (ASX:MVP) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxORkxYNzZraG5YM2FEcVdWRWtia2FpNjl6OVZrdUJYZlZXeHRITmRPY2l6OC1xdkIzWXZwTGh4aU5ZcW5jZFFNb09wajkyV0JIcUktVXNkLTJJNUxlTUpoVEMxTzV5R0REVjNialU2QlgzTkNmWDFHbmFhUlRTZFp0WFBJaVgzZ3NIN0wtLTV4b1Zqb3BGSjBFbE1mTmc?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-23T12:16:11+00:00", "published_display": "23 Sep 2019 12:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 9, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 6, "score": 55, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.41, "latest_week": "2026-07-10", "one_week_move": -2.4, "four_week_move": 5.2, "twelve_week_move": 8.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.423489, "market_dynamics_buy_signal": false, "relative_strength": -22.489101, "fair_value_gap": -32.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.5344, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.4% over one week, +5.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "intelligentinvestor.com.au", "count": 3}, {"label": "BiotechDispatch", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Kalkine", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.4% over one week, +5.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today"}], "updated_at": "2026-07-17T04:59:37.514451+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}